- Bayer and Hologic Collaborating to Deliver Contrast-Enhanced Mammography
- Hologic to Announce Financial Results for the Second Quarter of Fiscal 2024 on Thursday, May 2, 2024
- Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing
- Hologic to Unveil Groundbreaking AI Research at ECR 2024
- Hologic to Webcast Presentations at Upcoming Investor Conferences
- Hologic Announces First and Only FDA-Cleared Digital Cytology System – Genius™ Digital Diagnostics System
- Hologic Announces Financial Results for First Quarter of Fiscal 2024
More ▼
Key statistics
On Thursday, Hologic Inc (HOLX:NSQ) closed at 75.71, 18.26% above the 52 week low of 64.02 set on Oct 30, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 76.76 |
---|---|
High | 76.97 |
Low | 75.39 |
Bid | 72.01 |
Offer | 76.75 |
Previous close | 75.71 |
Average volume | 1.48m |
---|---|
Shares outstanding | 234.73m |
Free float | 233.00m |
P/E (TTM) | 35.99 |
Market cap | 17.77bn USD |
EPS (TTM) | 2.10 USD |
Data delayed at least 15 minutes, as of Apr 25 2024 21:00 BST.
More ▼